Lucy M. Hinder

2.3k total citations · 1 hit paper
32 papers, 1.6k citations indexed

About

Lucy M. Hinder is a scholar working on Physiology, Molecular Biology and Cell Biology. According to data from OpenAlex, Lucy M. Hinder has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Physiology, 15 papers in Molecular Biology and 7 papers in Cell Biology. Recurrent topics in Lucy M. Hinder's work include Adipose Tissue and Metabolism (14 papers), Pain Mechanisms and Treatments (11 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Lucy M. Hinder is often cited by papers focused on Adipose Tissue and Metabolism (14 papers), Pain Mechanisms and Treatments (11 papers) and Peroxisome Proliferator-Activated Receptors (7 papers). Lucy M. Hinder collaborates with scholars based in United States, United Kingdom and Germany. Lucy M. Hinder's co-authors include Eva L. Feldman, Phillipe D. O’Brien, Brian C. Callaghan, Subramaniam Pennathur, Andrea M. Vincent, Junguk Hur, John M. Hayes, Amy E. Rumora, Rodica Pop‐Busui and Anuradha Vivekanandan‐Giri and has published in prestigious journals such as Nature Communications, Journal of Neuroscience and Diabetes.

In The Last Decade

Lucy M. Hinder

31 papers receiving 1.5k citations

Hit Papers

Neurological consequences of obesity 2017 2026 2020 2023 2017 100 200 300

Peers

Lucy M. Hinder
Phillipe D. O’Brien United States
Corinne G. Jolivalt United States
Hoau-Yan Wang United States
Janelle M. Ryals United States
Catherine L. Stables United States
Paulo W. Pires United States
Phillipe D. O’Brien United States
Lucy M. Hinder
Citations per year, relative to Lucy M. Hinder Lucy M. Hinder (= 1×) peers Phillipe D. O’Brien

Countries citing papers authored by Lucy M. Hinder

Since Specialization
Citations

This map shows the geographic impact of Lucy M. Hinder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucy M. Hinder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucy M. Hinder more than expected).

Fields of papers citing papers by Lucy M. Hinder

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucy M. Hinder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucy M. Hinder. The network helps show where Lucy M. Hinder may publish in the future.

Co-authorship network of co-authors of Lucy M. Hinder

This figure shows the co-authorship network connecting the top 25 collaborators of Lucy M. Hinder. A scholar is included among the top collaborators of Lucy M. Hinder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucy M. Hinder. Lucy M. Hinder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eid, Stéphanie, Sarah E. Elzinga, Kai Guo, et al.. (2024). Transcriptomic profiling of sciatic nerves and dorsal root ganglia reveals site-specific effects of prediabetic neuropathy. Translational research. 270. 24–41.
2.
Guo, Kai, Claudia Figueroa‐Romero, Mohamed H. Noureldein, et al.. (2023). Gut microbiota in a mouse model of obesity and peripheral neuropathy associated with plasma and nerve lipidomics and nerve transcriptomics. Microbiome. 11(1). 52–52. 19 indexed citations
3.
Elzinga, Sarah E., Stéphanie Eid, Lucy M. Hinder, et al.. (2023). Transcriptomic analysis of diabetic kidney disease and neuropathy in mouse models of type 1 and type 2 diabetes. Disease Models & Mechanisms. 16(10). 4 indexed citations
4.
Eid, Stéphanie, Mohamed H. Noureldein, Bhumsoo Kim, et al.. (2023). Single‐cell RNA‐seq uncovers novel metabolic functions of Schwann cells beyond myelination. Journal of Neurochemistry. 166(2). 367–388. 14 indexed citations
5.
Rumora, Amy E., Kai Guo, Lucy M. Hinder, et al.. (2022). A High-Fat Diet Disrupts Nerve Lipids and Mitochondrial Function in Murine Models of Neuropathy. Frontiers in Physiology. 13. 921942–921942. 19 indexed citations
6.
Eid, Stéphanie, Phillipe D. O’Brien, Lucy M. Hinder, et al.. (2021). Differential effects of minocycline on microvascular complications in murine models of type 1 and type 2 diabetes. Journal of Translational Science. 7(1). 7 indexed citations
7.
Sajic, Marija, Amy E. Rumora, Giacomo Dentoni, et al.. (2021). High Dietary Fat Consumption Impairs Axonal Mitochondrial FunctionIn Vivo. Journal of Neuroscience. 41(19). 4321–4334. 26 indexed citations
8.
Eid, Stéphanie, Phillipe D. O’Brien, Lucy M. Hinder, et al.. (2020). Differential Effects of Empagliflozin on Microvascular Complications in Murine Models of Type 1 and Type 2 Diabetes. Biology. 9(11). 347–347. 24 indexed citations
9.
Guo, Kai, Sarah E. Elzinga, Stéphanie Eid, et al.. (2019). Genome-wide DNA methylation profiling of human diabetic peripheral neuropathy in subjects with type 2 diabetes mellitus. Epigenetics. 14(8). 766–779. 28 indexed citations
10.
O’Brien, Phillipe D., Kai Guo, Stéphanie Eid, et al.. (2019). Integrated lipidomic and transcriptomic analyses identify altered nerve triglycerides in mouse models of prediabetes and type 2 diabetes. Disease Models & Mechanisms. 13(2). 53 indexed citations
11.
Figueroa‐Romero, Claudia, Lucy M. Hinder, Karan Bedi, et al.. (2018). Abnormal RNA stability in amyotrophic lateral sclerosis. Nature Communications. 9(1). 2845–2845. 109 indexed citations
12.
Hinder, Lucy M., Benjamin J. Murdock, Diane E. Bender, et al.. (2018). Transcriptional networks of progressive diabetic peripheral neuropathy in the db/db mouse model of type 2 diabetes: An inflammatory story. Experimental Neurology. 305. 33–43. 47 indexed citations
13.
O’Brien, Phillipe D., Lucy M. Hinder, Brian C. Callaghan, & Eva L. Feldman. (2017). Neurological consequences of obesity. The Lancet Neurology. 16(6). 465–477. 363 indexed citations breakdown →
14.
Hur, Junguk, Phillipe D. O’Brien, Viji Nair, et al.. (2016). Transcriptional networks of murine diabetic peripheral neuropathy and nephropathy: common and distinct gene expression patterns. Diabetologia. 59(6). 1297–1306. 34 indexed citations
15.
O’Brien, Phillipe D., Lucy M. Hinder, Stacey A. Sakowski, & Eva L. Feldman. (2014). ER Stress in Diabetic Peripheral Neuropathy: A New Therapeutic Target. Antioxidants and Redox Signaling. 21(4). 621–633. 71 indexed citations
16.
Hinder, Lucy M., Claudia Figueroa‐Romero, Crystal Pacut, et al.. (2013). Long-Chain Acyl Coenzyme A Synthetase 1 Overexpression in Primary Cultured Schwann Cells Prevents Long Chain Fatty Acid-Induced Oxidative Stress and Mitochondrial Dysfunction. Antioxidants and Redox Signaling. 21(4). 588–600. 47 indexed citations
17.
Hinder, Lucy M., Andrea M. Vincent, Charles Burant, Subramaniam Pennathur, & Eva L. Feldman. (2012). Bioenergetics in diabetic neuropathy: what we need to know. Journal of the Peripheral Nervous System. 17(s2). 10–14. 35 indexed citations
18.
Hinder, Lucy M., Andrea M. Vincent, John M. Hayes, Lisa L. McLean, & Eva L. Feldman. (2012). Apolipoprotein E knockout as the basis for mouse models of dyslipidemia-induced neuropathy. Experimental Neurology. 239. 102–110. 30 indexed citations
19.
Vincent, Andrea M., Lucy M. Hinder, Rodica Pop‐Busui, & Eva L. Feldman. (2009). Hyperlipidemia: a new therapeutic target for diabetic neuropathy. Journal of the Peripheral Nervous System. 14(4). 257–267. 137 indexed citations
20.
Robinson, Lianne, Lucy M. Hinder, Roger G. Pertwee, & Gernot Riedel. (2003). Effects of Δ9-THC and WIN-55,212-2 on place preference in the water maze in rats. Psychopharmacology. 166(1). 40–50. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026